Why do we need to worry about antimicrobial resistance in the time of COVID-19?

  19 June 2020

The world is struggling hard to control the COVID-19 pandemic. This is difficult as the disease is new and we do not have specific drugs and vaccines to treat it or create immunity against it. What we have in our arsenal are the existing broad-spectrum antimicrobials.

Further reading: Down to Earth
Author(s): Vibha Varshney
Effective Surveillance  

Display your AMR technology / product:

Global AMR Technologies Database

  • Preventive – Diagnostic – Antimicrobial technologies
  • Academia – Research Institutes – Start ups – SMEs – Multinationals
  • Early research <-> near market
  • Global reach for funding / co-development / licensing
Display your technology and make use of the Continuous AMR Partnering Initiative >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!